Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/08/2013CA2530904C Pharmaceutical agents for the treatment of pain associated with spinal cord injury
10/08/2013CA2493629C Pramipexole once-daily dosage form
10/08/2013CA2486307C Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
10/08/2013CA2473938C Human adam-10 inhibitors
10/08/2013CA2457055C Process for producing 1,4-dihydroxy-2-naphthoic acid
10/08/2013CA2453403C Methods of inhibiting amyloid toxicity
10/08/2013CA2382817C Use of fibrin or fibrinogen for reducing lung tissue volume
10/08/2013CA2380753C Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor
10/08/2013CA2359244C .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
10/08/2013CA2353867C Anticancer agents based on prevention of protein prenylation
10/08/2013CA2349839C Ucp5
10/08/2013CA2238893C Il-13 receptor polypeptide
10/03/2013WO2013149258A2 Compositions and methods for treating or preventing metabolic syndrome disorders
10/03/2013WO2013149250A1 Methods of treatment, diagnosis and monitoring for methamphetamine toxicity which target ceramide metabolic pathways and cellular senescence
10/03/2013WO2013149190A1 Pharmaceutical compositions and methods for treatment of fungal infections
10/03/2013WO2013149161A1 High molecular weight heparosan polymers and methods of production and use thereof
10/03/2013WO2013149148A2 Dosage forms of halofuginone and methods of use
10/03/2013WO2013149147A1 Mesylate salt forms of a potent hcv inhibitor
10/03/2013WO2013149136A1 ISOXAZOLE β-LACTAMASE INHIBITORS
10/03/2013WO2013149124A1 Small molecule inhibitors of mcl-1 and uses thereof
10/03/2013WO2013149121A1 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
10/03/2013WO2013149109A1 Colchicine formulations; methods of making; and methods of use thereof
10/03/2013WO2013149102A1 Compositions comprising scopolamine and ketamine in the treatment of depression
10/03/2013WO2013149091A1 Composition and method for treating neurodegenerative disease
10/03/2013WO2013149026A2 Use of n-(4-((3-(2-amino-4-pyrimidinyl) -2-pyridinyl)oxy)phenyl)-4-(4-methyl -2-thienyl)-1-phthalazinamine in combination with histone deacetylase inhibitors for treatment of cancer
10/03/2013WO2013149017A1 Vaccine adjuvant
10/03/2013WO2013148994A1 Glucose transporter inhibitors
10/03/2013WO2013148978A1 Methods and compositions for the treatment of necrotizing enterocolitis
10/03/2013WO2013148919A1 Treatment of multiple myeloma
10/03/2013WO2013148912A1 Compounds for use in the treatment of neuroblastoma, ewing's sarcoma or rhabdomyosarcoma
10/03/2013WO2013148896A1 Ocular treatment solutions, delivery devices and delivery augmentation methods
10/03/2013WO2013148891A1 Parenteral formulations for administering macrolide antibiotics
10/03/2013WO2013148874A1 Anti-inflammatory macrolides
10/03/2013WO2013148864A1 Curaxins for use in treating breast cancer and method for identifying patients likely to respond
10/03/2013WO2013148857A1 Triazole derivatives as hsp90 inhibitors
10/03/2013WO2013148851A1 Compounds for treating neurodegenerative diseases
10/03/2013WO2013148824A1 METHODS AND COMPOSITIONS TO TREAT CANCER USING BIFUNCTIONAL SRC-3 shRNA
10/03/2013WO2013148813A1 Triazolothienopyrimidine compound inhibitors of urea transporters and methods of using inhibitors
10/03/2013WO2013148791A1 Novel alkylated imino sugars exhibiting glucosidase inhibition and their method of use
10/03/2013WO2013148768A1 Crystalline forms of (r)-3-[n-(3'-chlorobiphenyl-4-ylmethyl)-n'-(3-hydroxyisoxazole-5-carbonyl)hydrazino]-2-hydroxypropionic acid isopropyl ester
10/03/2013WO2013148748A1 Lactam kinase inhibitors
10/03/2013WO2013148740A1 4–aminopyridine as a therapeutic agent for spinal muscular atrophy
10/03/2013WO2013148736A1 Compositions and treatments based on cadherin modulation
10/03/2013WO2013148710A1 Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy
10/03/2013WO2013148709A1 Ipa as a therapeutic agent, as a protective agent, and as a biomarker of disease risk
10/03/2013WO2013148690A1 Treatment of multiple sclerosis with combination of laquinimod and dimethyl fumarate
10/03/2013WO2013148649A1 Use of survivin antagonists in polyomavirus-related disease
10/03/2013WO2013148638A2 Compositions and methods related to inhibitors of jak kinase
10/03/2013WO2013148631A1 Cyclic prodrugs of duocarmycin analogs
10/03/2013WO2013148620A1 Benzofuran derivatives for the treatment of hepatitis c
10/03/2013WO2013148603A1 Cinnoline derivatives as as btk inhibitors
10/03/2013WO2013148584A1 Schweinfurthin analogues
10/03/2013WO2013148572A1 Blocking of cue-induced drug reinstatement
10/03/2013WO2013148478A1 Thrombin inhibitors
10/03/2013WO2013148366A1 Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
10/03/2013WO2013148365A1 Phenyl-urea and phenyl-carbamate derivatives as inhibitors of protein aggregation
10/03/2013WO2013148337A1 Methods for treating neoplasia
10/03/2013WO2013148333A1 Salicylic acid derivatives useful as glucocerebrosidase activators
10/03/2013WO2013148324A1 Anti-cancer polyketide compounds
10/03/2013WO2013148282A1 Methods and materials related to nutritional supplement compositions containing a potato polysaccharide preparation
10/03/2013WO2013148269A1 Methods and compositions for reducing the proliferation of gram positive bacteria
10/03/2013WO2013148230A1 Polyamine transport selective therapeutic agents with enhanced stability
10/03/2013WO2013148227A1 Insulin-like growth factor-1 receptor inhibitors
10/03/2013WO2013148219A1 Anti-metatstatic agents predicated upon polyamine-macrocyclic conjugates
10/03/2013WO2013148197A1 Compositions and methods for reactivating latent immunodeficiency virus
10/03/2013WO2013148183A2 Compositions and methods for inhibiting drusen
10/03/2013WO2013148174A1 New anti-mycobacterial drugs against tuberculosis
10/03/2013WO2013148164A1 Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses
10/03/2013WO2013148136A1 Omega-3 fatty acid ester compositions
10/03/2013WO2013148134A1 Methods for modulating cell-mediated immunity using human milk oligosaccharides
10/03/2013WO2013148130A1 Inhibition of memapsin 1 cleavage in the treatment of diabetes
10/03/2013WO2013148114A1 P300/cbp inhibitors and methods of use
10/03/2013WO2013148103A1 Novel compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system
10/03/2013WO2013148072A1 Administration of eritoran or pharmaceutically acceptable salts thereof to treat orthomyxovirus infections
10/03/2013WO2013147965A1 Medical compositions, methods of making and using those compositions, and kits including those compositions
10/03/2013WO2013147921A1 Polyvinylpyrrolidone-containing acetaminophen liquid formulations
10/03/2013WO2013147899A1 Osteoprotegerin derived composition and use thereof
10/03/2013WO2013147750A1 Oral combination therapy for treating hcv infection in specific patient sub-population
10/03/2013WO2013147749A1 Oral combination therapy for treating hcv infection in specific patient subgenotype populations
10/03/2013WO2013147711A1 Bicyclic heterocyclic derivatives as mnk1 and mnk2 modulators and uses thereof
10/03/2013WO2013147690A1 Method for treatment of labor arrest
10/03/2013WO2013147689A1 Combination treatment comprising sulphated glycosaminoglycans for inducing labor
10/03/2013WO2013147687A1 A nicotine oral delivery product containing a powder enclosed in a water insoluble pouch, wherein said powder comprises nicotine and a chewing gum composition
10/03/2013WO2013147651A2 Pharmaceutical composition having antimicrobial and bacteriostatic action(alternatives)
10/03/2013WO2013147645A1 Method for producing drugs and biologically active agents
10/03/2013WO2013147630A1 Methoxy and methylthio derivatives of trans-stilbene and their use
10/03/2013WO2013147629A1 The new derivatives of (z)-1,2-diphenylethene
10/03/2013WO2013147618A1 Ionophore antibiotic suspension
10/03/2013WO2013147585A1 A composition having antiviral activity against flavivirus
10/03/2013WO2013147577A1 Semi-solid topical composition which contains pirfenidone and modified diallyl disulphide oxide (m-ddo) for eliminating or preventing acne
10/03/2013WO2013147568A1 Aminostyrylbenzofuran derivatives as inhibitors against beta-amyloid fibril formation, and pharmaceutical composition comprising same
10/03/2013WO2013147556A1 Pharmaceutical composition for preventing or treating hearing loss, containing cilostazol and ginkgo leaf extract as active ingredients
10/03/2013WO2013147462A1 Pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt
10/03/2013WO2013147458A1 Process of preparing solifenacin or salt thereof, and novel intermediate used in the process
10/03/2013WO2013147452A1 Pharmaceutical composition in form of non-aqueous liquid comprising revaprazan or its salt
10/03/2013WO2013147451A1 Pharmaceutical composition containing branched chain amino acid, and production method therefor
10/03/2013WO2013147419A1 A composition comprising the compound isolated from chrysanthemum indicum for treating or preventing cerebrovascular system involved anxiety and the use thereof
10/03/2013WO2013147414A1 Pharmaceutical composition and preparation method thereof
10/03/2013WO2013147263A1 Novel use of acetyltransferase competitive inhibitory factor gm16515
10/03/2013WO2013147232A1 Bionanocapsule having antibody against surface protein of dendritic cell
1 ... 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 ... 7860